Nanomedicine News

RSS
NanoViricides Acquires cGMP-Compliant Manufacturing and R&D Facility from Inno-Haven

NanoViricides Acquires cGMP-Compliant Manufacturing and R&D Facility from Inno-Haven

Blend Secures $21 Million Funding to Create mBDCs Encapsulated in Nanoparticles

Blend Secures $21 Million Funding to Create mBDCs Encapsulated in Nanoparticles

ProNAi Commences Treatment in Wolverine Phase II Study for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

ProNAi Commences Treatment in Wolverine Phase II Study for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

BIND Therapeutics Enrolls First Patient Expressing KRAS Mutation in Global BIND-014 Phase 2 Trial in NSCLC Patients

BIND Therapeutics Enrolls First Patient Expressing KRAS Mutation in Global BIND-014 Phase 2 Trial in NSCLC Patients

Graphene Strip Flying Carpets Deliver Two Anticancer Drugs Sequentially

Graphene Strip Flying Carpets Deliver Two Anticancer Drugs Sequentially

Celsion Submits Phase I Clinical Trial Protocol for GEN-1 DNA-Based Immunotherapy with Nanoparticle Delivery System

Celsion Submits Phase I Clinical Trial Protocol for GEN-1 DNA-Based Immunotherapy with Nanoparticle Delivery System

OSU's New System Using Nanoparticles Can Improve Cancer Surgery, Phototherapy

OSU's New System Using Nanoparticles Can Improve Cancer Surgery, Phototherapy

IND Submitted to CFDA for STP705 Anti-Fibrosis RNAi to Treat Human Skin Hypertrophic Scars

IND Submitted to CFDA for STP705 Anti-Fibrosis RNAi to Treat Human Skin Hypertrophic Scars

Tekmira Completes Enrolment in TKM-PLK1 Phase I/II Clinical Study in Advanced GI-NET and ACC

Tekmira Completes Enrolment in TKM-PLK1 Phase I/II Clinical Study in Advanced GI-NET and ACC

Researchers Combine Antioxidant Biomaterials with Calcium Nanocrystals to Create Bone-Like Material

Researchers Combine Antioxidant Biomaterials with Calcium Nanocrystals to Create Bone-Like Material

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.